We are live on ! Find out more
BRA

Blue Rock Advisors Portfolio holdings

AUM $7K
This Fund
S&P 500
This Quarter Est. Return
+11.84%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$89.6M
Cap. Flow
+$90.3M
Cap. Flow %
77.94%
Top 10 Hldgs %
38.26%
Holding
111
New
67
Increased
16
Reduced
3
Closed
25

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$8.56M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.63M
3
LLY icon
Eli Lilly
LLY
+$7.18M
4
BAX icon
Baxter International
BAX
+$5.3M
5
LH icon
Labcorp
LH
+$3.55M

Top Sells

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$1.34M
2
APH icon
Amphenol
APH
+$1.04M
3
NVDA icon
NVIDIA
NVDA
+$936K
4
MXIM
Maxim Integrated Products
MXIM
+$897K
5
SHOP icon
Shopify
SHOP
+$873K

Sector Composition

Rank Sector Weight
1 Healthcare 42.52%
2 Technology 27.92%
3 Consumer Discretionary 14.81%
4 Industrials 4.41%
5 Consumer Staples 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$112B
$8.86M 7.65%
+85,267
New +$8.56M
BMY icon
2
Bristol-Myers Squibb
BMY
$129B
$7.64M 6.59%
+126,737
New +$7.63M
LLY icon
3
Eli Lilly
LLY
$1.08T
$6.87M 5.93%
+46,395
New +$7.18M
BAX icon
4
Baxter International
BAX
$12.8B
$5.07M 4.37%
+63,004
New +$5.3M
LH icon
5
Labcorp
LH
$25.2B
$3.62M 3.13%
+22,402
New +$3.55M
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.08M 2.66%
+39,679
New +$2.73M
CCXI
7
DELISTED
ChemoCentryx, Inc.
CCXI
$2.95M 2.54%
+53,784
New +$2.9M
ARNA
8
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.38M 2.05%
+31,780
New +$2.12M
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$123B
$1.94M 1.68%
+7,142
New +$1.97M
MDB icon
10
MongoDB
MDB
$25.8B
$1.92M 1.66%
+8,293
New +$1.8M
MCHP icon
11
Microchip Technology
MCHP
$38.8B
$1.92M 1.65%
37,300
+26,894
+258% +$1.4M
DOCU
12
DocuSign
DOCU
$11.1B
$1.89M 1.63%
8,775
+3,030
+53% +$629K
AMZN icon
13
Amazon
AMZN
$2.44T
$1.75M 1.51%
11,120
+6,980
+169% +$1.1M
GPN icon
14
Global Payments
GPN
$24.1B
$1.75M 1.51%
+9,846
New +$1.7M
ZEN
15
DELISTED
ZENDESK INC
ZEN
$1.75M 1.51%
+16,967
New +$1.59M
TTD icon
16
Trade Desk
TTD
$8.97B
$1.73M 1.49%
33,290
+12,200
+58% +$557K
AMAT icon
17
Applied Materials
AMAT
$347B
$1.59M 1.37%
26,692
+5,225
+24% +$323K
CRDF icon
18
Cardiff Oncology
CRDF
$63M
$1.51M 1.3%
+106,481
New +$703K
TEAM icon
19
Atlassian
TEAM
$26.5B
$1.51M 1.3%
+8,303
New +$1.48M
WDAY icon
20
Workday
WDAY
$41.5B
$1.45M 1.25%
+6,738
New +$1.33M
CPRI icon
21
Capri Holdings
CPRI
$1.82B
$1.44M 1.24%
+79,722
New +$1.35M
XYZ
22
Block Inc
XYZ
$48.9B
$1.42M 1.23%
+8,761
New +$1.24M
VEEV icon
23
Veeva Systems
VEEV
$33.8B
$1.42M 1.22%
+5,037
New +$1.33M
ST icon
24
Sensata Technologies
ST
$6.69B
$1.39M 1.2%
32,238
+27,225
+543% +$1.11M
RCL icon
25
Royal Caribbean
RCL
$86.5B
$1.39M 1.2%
+21,431
New +$1.26M

Similar funds

Blue Rock Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Blue Rock Advisors held 111 positions worth $116M, up 342% from $26.2M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Blue Rock Advisors deployed $90.3M of net new capital in Q3 2020, opening 67 new positions and adding to 16 existing holdings. Its largest new stake was Medtronic: 85,267 shares worth $8.86M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lumentum, an estimated $459K trimmed.

  • Blue Rock Advisors's largest Q3 2020 buy was Medtronic: 85,267 shares worth $8.86M.
  • Blue Rock Advisors added most to Microchip Technology in Q3 2020, an estimated $1.4M increase.
  • Blue Rock Advisors's biggest Q3 2020 reduction was Lumentum, cutting an estimated $459K.
  • Blue Rock Advisors fully exited Autodesk in Q3 2020, selling an estimated $1.34M.
  • Blue Rock Advisors's ten largest holdings make up 38% of its $116M portfolio in Q3 2020.
  • Blue Rock Advisors opened 67 new positions and closed 25 in Q3 2020.
  • Blue Rock Advisors's portfolio value rose 342% quarter-over-quarter to $116M.

Based on Blue Rock Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.